Markets:

Overview

News

Currencies

International

Treasuries

Medtronic (NY:MDT)

87.75 +0.87 (+1.00%)

Streaming Delayed Price Updated: 10:44 AM EDT, Jul 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9

...

66 67 Next >

Medtronic, Genuine Parts And 3 Stocks To Watch Heading Into Tuesday ↗

February 17, 2026

US stock futures lower. Medtronic, Genuine Parts, Sonoco, Fluor, and Toll Brothers expected to report earnings today.

Via Benzinga

Baxter International (BAX) Deep Dive: Navigating the 16% Plunge and a New Strategic Era

February 16, 2026

On February 16, 2026, the mood surrounding Baxter International (NYSE: BAX) is one of cautious sobriety following a seismic shift in investor confidence. Long regarded as a defensive staple of the...

Via Finterra

Uncovering Potential: Medtronic's Earnings Preview ↗

February 16, 2026

Via Benzinga

3 Dividend Stocks to Double Up On Right Now ↗

February 16, 2026

Dividend-paying stocks tend to greatly outperform non-payers. Here are three promising dividend payers.

Via The Motley Fool

Topics Artificial Intelligence Economy

Medtronic PLC (NYSE:MDT): A Durable Dividend Stock for Income Investors ↗

February 16, 2026

Via Chartmill

Medtronic PLC (NYSE:MDT) Shows High-Probability Technical Breakout Setup ↗

January 28, 2026

Via Chartmill

Option Volatility And Earnings Report For February 16 - 20

February 16, 2026

Earnings season is starting to slow down now, which may come as a welcome relief for some. However, we do still have some important companies due to report with Walmart, Alibaba, Newmont Mining,...

Via Barchart.com

Stock Market Today, Feb. 13: Inflation Data Steadies Market and Slows AI Disruption Losses ↗

February 13, 2026

Positive earnings pushed Applied Materials and Rivian Automotive higher as better-than-expected inflation data helped steady markets today, Feb. 13, 2026.

Via The Motley Fool

Topics Artificial Intelligence Earnings Economy

Medtronic Wins FDA Nod For Spine Surgery Tech Designed To Cut Repeat Imaging ↗

February 13, 2026

Medtronic's Stealth AXiS spine surgery system wins FDA clearance, offering real-time alignment tracking and broader surgical flexibility.

Via Benzinga

Peering Into Medtronic PLC's Recent Short Interest ↗

February 12, 2026

Via Benzinga

Pure-Play Pivot: A Deep Dive into Becton Dickinson (BDX) Following the Waters Spin-Off and 2026 Guidance Reset

February 11, 2026

Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has long been a cornerstone of the global healthcare infrastructure. However, as of February 11, 2026, the company is making headlines not...

Via Finterra

Topics Artificial Intelligence Economy Intellectual Property

Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days

February 10, 2026

Via AB Newswire

Intuitive Surgical’s New Heart: Analyzing the da Vinci 5 Cardiac Clearance and the Future of Robotic Surgery

February 09, 2026

As of February 9, 2026, the medtech landscape is witnessing a pivotal shift centered around the long-awaited return of robotics to the heart of the operating room. Intuitive Surgical, Inc. (NASDAQ:...

Via Finterra

Topics Artificial Intelligence Economy World Trade

Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination

February 09, 2026

Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5...

Via Finterra

Topics Artificial Intelligence Economy Product Recall

What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill. ↗

February 08, 2026

These companies pay very healthy dividends.

Via The Motley Fool

Topics Bonds

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

February 07, 2026

Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.

Via The Motley Fool

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for...

Via MarketMinute

Topics Supply Chain

Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)

February 05, 2026

February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left...

Via Finterra

Topics Product Recall World Trade

Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors ↗

February 04, 2026

Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.

Via The Motley Fool

Topics Earnings Stocks

2 Healthcare Dividend Stocks That are Just What the Doctor Ordered ↗

February 03, 2026

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.

Via The Motley Fool

Topics Intellectual Property

Medtronic Bets On AI Heart Care With $585 Million Deal For Partner CathWorks ↗

February 03, 2026

Medtronic plans to acquire heart imaging firm CathWorks for up to $585 million, expanding its digital heart care tools as the deal awaits U.S. regulatory approval.

Via Benzinga

Topics Artificial Intelligence

Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race

February 02, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The...

Via MarketMinute

Topics Artificial Intelligence

Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink?

February 02, 2026

Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Via Barchart.com

Topics ETFs Stocks

2 AI Surgery Stocks to Buy Hand Over Fist in February ↗

January 30, 2026

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the heart of it.

Via The Motley Fool

Topics Artificial Intelligence

Foundation for the AI Era: Texas Instruments Commences Volume Production at $60 Billion SM1 ‘Mega-Fab’ in Sherman, Texas

January 30, 2026

In a landmark moment for the American semiconductor industry, Texas Instruments (NASDAQ: TXN) has officially commenced volume production at its state-of-the-art SM1 fab in Sherman, Texas. The facility,...

Via TokenRing AI

Topics Artificial Intelligence Economy Supply Chain

Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation

January 28, 2026

MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra...

Via MarketMinute

The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants

January 27, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)...

Via MarketMinute

Caterpillar, Medtronic, Transocean And A Financial Stock: CNBC's 'Final Trades' ↗

January 26, 2026

CNBC's Halftime Report: Bryn Talkington sticking with Capital One (COF) expecting it to rise to $250 in a year. Kevin Simpson chooses Medtronic (MDT).

Via Benzinga

Johnson & Johnson 2026 Outlook: Chasing the $100 Billion Milestone Amidst Legal and Patent Hurdles

January 23, 2026

Following a resilient performance throughout 2025, healthcare giant Johnson & Johnson (NYSE: JNJ) has officially set its sights on a historic milestone for 2026. In its latest earnings report released...

Via MarketMinute

Topics Artificial Intelligence Bankruptcy Economy

Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026

January 23, 2026

As of January 23, 2026, Johnson & Johnson (NYSE:JNJ) finds itself at a historic crossroads. After spending much of 2025 navigating the "patent cliff" of its blockbuster drug Stelara and finalizing its...

Via MarketMinute

Topics Artificial Intelligence Bankruptcy Economy

< Previous 1 2 3 4 5 6 7 8 9

...

66 67 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.